NASDAQ: CING
Cingulate Inc Stock Forecast, Predictions & Price Target

Analyst price target for CING

Based on 3 analysts offering 12 month price targets for Cingulate Inc

Min Forecast
$12.00+187.08%
Avg Forecast
$30.67+633.66%
Max Forecast
$60.00+1,335.41%

Should I buy or sell CING stock?

Based on 3 analysts offering ratings for Cingulate Inc.

Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CING's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CING as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their CING stock forecasts and price targets.

CING stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-21
lockedlocked$00.00+00.00%2025-03-06
lockedlocked$00.00+00.00%2025-01-10

1 of 1

Forecast return on equity

Is CING forecast to generate an efficient return?

Company
-104.8%
Industry
1,370.01%
Market
72.98%
CING's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CING forecast to generate an efficient return on assets?

Company
-52.56%
Industry
985.04%
CING is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CING earnings per share forecast

What is CING's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$2.96
Avg 2 year Forecast
-$2.07

CING revenue forecast

What is CING's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$7.8M

CING vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CING$4.18$30.67+633.66%Strong Buy
EQ$0.44$1.00+127.27%Hold
LPTX$0.39$5.50+1,321.19%Buy
PHGE$0.62$21.00+3,276.21%Buy
NRXS$2.22N/AN/A

Cingulate Stock Forecast FAQ

Is Cingulate Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CING) stock is to Strong Buy CING stock.

Out of 3 analysts, 1 (33.33%) are recommending CING as a Strong Buy, 2 (66.67%) are recommending CING as a Buy, 0 (0%) are recommending CING as a Hold, 0 (0%) are recommending CING as a Sell, and 0 (0%) are recommending CING as a Strong Sell.

If you're new to stock investing, here's how to buy Cingulate stock.

What is CING's earnings growth forecast for 2025-2026?

(NASDAQ: CING) Cingulate's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 31.52%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 66.53%.

Cingulate's earnings in 2025 is -$15,545,737.On average, 4 Wall Street analysts forecast CING's earnings for 2025 to be -$11,135,622, with the lowest CING earnings forecast at -$14,470,656, and the highest CING earnings forecast at -$8,780,372.

In 2026, CING is forecast to generate -$7,813,024 in earnings, with the lowest earnings forecast at -$13,076,348 and the highest earnings forecast at -$1,017,468.

What is CING's revenue growth forecast for 2026-2026?

(NASDAQ: CING) Cingulate's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 3,213.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.92%.

Cingulate's revenue in 2025 is $0.

In 2026, CING is forecast to generate $29,280,468 in revenue, with the lowest revenue forecast at $29,280,468 and the highest revenue forecast at $29,280,468.

What is CING's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: CING) forecast ROA is -52.56%, which is lower than the forecast US Biotechnology industry average of 985.04%.

What is CING's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CING price target, the average CING price target is $30.67, with the highest CING stock price forecast at $60.00 and the lowest CING stock price forecast at $12.00.

On average, Wall Street analysts predict that Cingulate's share price could reach $30.67 by Apr 21, 2026. The average Cingulate stock price prediction forecasts a potential upside of 633.66% from the current CING share price of $4.18.

What is CING's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: CING) Cingulate's current Earnings Per Share (EPS) is -$10.20. On average, analysts forecast that CING's EPS will be -$2.96 for 2025, with the lowest EPS forecast at -$3.84, and the highest EPS forecast at -$2.33. In 2026, CING's EPS is forecast to hit -$2.07 (min: -$3.47, max: -$0.27).

What is CING's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: CING) forecast ROE is -104.8%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.